The IC50 values determined by the CCK-8 assay for gefitinib in HCC827/GR cells decreased by using firsocostat, and ACC1 knockdown, indicating that ACC1 promotes the formation of gefitinib resistance in NSCLC cells (Fig. 7D-7E). The gene discussed is ACACA; the disease is non-small cell lung carcinoma.